| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
491,390,000 |
| Market
Cap: |
8.30(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.08 - $16.46 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 11.5 |
| Insider 6 Months : 11.5 |
| Insider 3/6 Months : 23 |
|
| Guru Rank Number : 235 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Elanco Animal Health is an animal health company. Co. groups its products into four principal categories: Companion Animal (CA) Disease Prevention, which includes parasiticides and vaccine products for canines and felines; CA Therapeutics, which includes products for the treatment of pain, osteoarthritis, otitis, cardiovascular and dermatology indications in canines and felines; Food Animal (FA) Future Protein and Health, which includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production; and FA Ruminants and Swine, which includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
38,100 |
38,100 |
38,100 |
157,300 |
| Total Buy Value |
$617,802 |
$617,802 |
$617,802 |
$2,415,734 |
| Total People Bought |
3 |
3 |
3 |
7 |
| Total Buy Transactions |
3 |
3 |
3 |
12 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kinard David S |
SEE REMARKS |
• – – |
2022-03-01 |
4 |
D |
$28.94 |
$49,893 |
D/D |
(1,724) |
95,517 |
|
- |
|
| Kinard David S |
SEE REMARKS |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,665 |
97,241 |
|
- |
|
| Correia De Simas Jose Manuel |
SEE REMARKS |
• – – |
2022-03-01 |
4 |
D |
$28.94 |
$16,583 |
D/D |
(573) |
21,779 |
|
- |
|
| Correia De Simas Jose Manuel |
SEE REMARKS |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,123 |
22,352 |
|
- |
|
| De Brabander Ellen |
SEE REMARKS |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,496 |
60,131 |
|
- |
|
| Kirberger Marcela A. |
SEE REMARKS |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,583 |
19,155 |
|
- |
|
| Young Todd S. |
SEE REMARKS |
• – – |
2022-03-01 |
4 |
D |
$28.94 |
$108,438 |
D/D |
(3,747) |
122,084 |
|
- |
|
| Young Todd S. |
SEE REMARKS |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
21,683 |
125,831 |
|
- |
|
| Cabral Ramiro Martin |
SEE REMARKS |
• – – |
2022-03-01 |
4 |
D |
$28.94 |
$54,754 |
D/D |
(1,892) |
84,192 |
|
- |
|
| Cabral Ramiro Martin |
SEE REMARKS |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,699 |
86,084 |
|
- |
|
| Simmons Jeffrey N |
PRESIDENT, CEO AND DIRECTOR |
• • – |
2022-03-01 |
4 |
D |
$28.94 |
$145,597 |
D/D |
(5,031) |
772,553 |
|
- |
|
| Simmons Jeffrey N |
PRESIDENT, CEO AND DIRECTOR |
• • – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
88,114 |
777,584 |
|
- |
|
| Anand Kapila K |
|
– • – |
2022-03-01 |
4 |
B |
$28.48 |
$28,479 |
D/D |
1,000 |
27,467 |
0.01 |
-30% |
|
| Hoover R David |
See Remarks |
– • – |
2022-03-01 |
4 |
B |
$28.66 |
$143,323 |
I/I |
5,000 |
110,000 |
2.1 |
-30% |
|
| Meer James M |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-02-22 |
4 |
D |
$25.98 |
$32,813 |
D/D |
(1,263) |
17,027 |
|
- |
|
| Meer James M |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,683 |
18,290 |
|
- |
|
| Kinard David S |
See Remarks |
• – – |
2022-02-22 |
4 |
D |
$25.98 |
$244,212 |
D/D |
(9,400) |
88,576 |
|
- |
|
| Kinard David S |
See Remarks |
• – – |
2022-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
22,598 |
97,976 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2022-02-22 |
4 |
D |
$25.98 |
$346,339 |
D/D |
(13,331) |
73,385 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2022-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
32,339 |
86,716 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2022-02-22 |
4 |
D |
$25.98 |
$267,724 |
D/D |
(10,305) |
84,778 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2022-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
24,841 |
95,083 |
|
- |
|
| Young Todd S. |
See Remarks |
• – – |
2022-02-22 |
4 |
D |
$25.98 |
$586,031 |
D/D |
(22,557) |
104,148 |
|
- |
|
| Young Todd S. |
See Remarks |
• – – |
2022-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
55,205 |
126,705 |
|
- |
|
| Simmons Jeffrey N |
President, CEO and Director |
• • – |
2022-02-22 |
4 |
D |
$25.98 |
$2,414,789 |
D/D |
(92,948) |
689,470 |
|
- |
|
390 Records found
|
|
Page 7 of 16 |
|
|
3.37 (24.93%) 
